Healthcare Services

One of the Major Drivers of the Urticaria Market Is the Rising Skin Disease Awareness Fueling Growth Of The Market Due To Greater Focus On Early Detection And Treatment

April 7, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Urticaria Market During The Forecast Period 2026–2030?

The urticaria market has seen rapid expansion in recent years. Its value is anticipated to increase from $4.76 billion in 2025 to $5.61 billion in 2026, at a compound annual growth rate (CAGR) of 17.9%. Historical growth can be attributed to a higher incidence of allergic skin conditions, more extensive use of antihistamines, the broadening of dermatology treatment services, increased public understanding of chronic urticaria, and the introduction of prescription therapies.

The urticaria market is anticipated to undergo significant expansion in the coming years. It is forecast to achieve a valuation of $10.71 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.5%. This growth throughout the forecast period can be primarily attributed to the increasing adoption of biologic treatments, a rising demand for long-acting therapies, a growing emphasis on immune-modulating drugs, the expansion of specialty dermatology clinics, and increased investment in allergy and immunology research. Key trends expected during this period include the accelerated development of biologic and monoclonal antibody therapies, a growing application of personalized treatment approaches, an enhanced focus on chronic urticaria management, the broader availability of advanced antihistamine formulations, and a strengthened commitment to long-term disease control.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23554&type=smp

What Drivers Are Expected To Influence The Urticaria Market During The Forecast Period?

Increased understanding and management of skin conditions are projected to propel the expansion of the urticaria market going forward. A rise in environmental pollution leads to a greater incidence of skin allergies and various dermatological issues, thereby fueling the demand for public awareness and advanced treatments. Urticaria contributes to skin disease awareness and treatment by showcasing immune system responses, stimulating further research, enhancing diagnostic methods, and advancing targeted therapies. For instance, in February 2024, The Skin Cancer Foundation, a US-based nonprofit, reported that 1 in 5 Americans develop skin cancer by age 70, with over 2 deaths occurring every hour in the U.S. This highlights the urgent need for preventative measures, as having five or more sunburns doubles the risk of melanoma. Consequently, heightened skin disease awareness and improved treatment options are driving the growth of the urticaria market.

What Market Segments Are Evaluated Within The Urticaria Market?

The urticaria market covered in this report is segmented –

1) By Type: Acute Urticaria, Chronic Urticaria

2) By Drug Class: Antihistamines, Anti-inflammation Medications, Antidepressants, Monoclonal Antibodies, Other Drug Classes

3) By Route of Administration: Oral, Parenteral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Acute Urticaria: Allergic Urticaria, Infectious Urticaria, Drug-Induced Urticaria, Contact Urticaria

2) By Chronic Urticaria: Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU)

What Key Trends Are Influencing The Development Of The Urticaria Market?

Companies operating within the urticaria market are intensely focused on creating innovative solutions, including mast cell inhibitor antibodies, to advance therapeutic options for chronic spontaneous urticaria by targeting mast cell activation. A mast cell inhibitor antibody serves as a targeted monoclonal antibody, effectively blocking the activation or degranulation of mast cells by inhibiting specific receptors or signaling pathways, which in turn reduces allergic reactions, inflammation, and other disorders mediated by mast cells. For example, Allakos Inc., a US-based biotechnology company, announced in May 2024 the launch of a Phase 1 clinical trial for AK006, designed to treat chronic spontaneous urticaria (CSU). This innovative therapy targets both IgE-dependent and IgE-independent mast cell activation pathways, holding the potential for wider efficacy in patients who have not responded to antihistamines or prior biologic treatments. By selectively inhibiting mast cell activity through the Siglec-6 receptor, AK006 seeks to offer a more thorough and lasting solution for CSU management, marking a significant step forward in urticaria treatment and immunotherapy research.

Who Are The Top Market Participants Influencing The Urticaria Market?

Major companies operating in the urticaria market are Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Roche Holding AG, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Incyte Corporation, Kyowa Kirin Co. Ltd, Argenx SE, Allakos Inc, AstraZeneca plc, Kiniksa Pharmaceuticals Ltd, United BioPharma Inc, Celldex Therapeutics Inc, Yuhan Corporation, Hangzhou Highlightll Pharmaceutical Co Ltd, Evommune Inc, Rapt Therapeutics Inc, Enanta Pharmaceuticals Inc, UCB Pharma

Read the full urticaria market report here:

https://www.thebusinessresearchcompany.com/report/urticaria-global-market-report

Which Region Is Forecast To Lead The Urticaria Market In Terms Of Market Size?

North America was the largest region in the urticaria market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urticaria market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Urticaria Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=23554&type=smp

Browse Through More Reports Similar to the Global Urticaria Market 2026, By The Business Research Company

Dermatitis Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Ursolic Acid Global Market Report

https://www.thebusinessresearchcompany.com/report/ursolic-acid-global-market-report

Allergic Rhinitis Global Market Report

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795